Publication: Impact of Eculizumab on Hospitalization Rates and Relapse Treatment in Patients with Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder: the Phase 3 PREVENT Study
| dc.authorwosid | Nakashima, Ichiro/Aac-3073-2019 | |
| dc.authorwosid | Wang, Kaichen/Iuq-5705-2023 | |
| dc.authorwosid | Levy, Michael/A-3268-2011 | |
| dc.authorwosid | Pittock, Sean/Ael-3538-2022 | |
| dc.authorwosid | Terzi̇, Murat/Aaa-1284-2021 | |
| dc.authorwosid | Palace, Jacqueline/Aff-7912-2022 | |
| dc.contributor.author | Kim, Ho Jin | |
| dc.contributor.author | Pittock, Sean J. | |
| dc.contributor.author | Berthele, Achim | |
| dc.contributor.author | Fujihara, Kazuo | |
| dc.contributor.author | Levy, Michael | |
| dc.contributor.author | Palace, Jacqueline | |
| dc.contributor.author | Wingerchuk, Dean M. | |
| dc.date.accessioned | 2025-12-11T00:48:57Z | |
| dc.date.issued | 2020 | |
| dc.department | Ondokuz Mayıs Üniversitesi | en_US |
| dc.department-temp | [Kim, Ho Jin] Natl Canc Ctr, Res Inst & Hosp, Goyang, South Korea; [Pittock, Sean J.] Mayo Clin, Rochester, MN USA; [Berthele, Achim] Tech Univ Munich, Klinikum Rechts Isar, Munich, Germany; [Fujihara, Kazuo; Nakashima, Ichiro] Tohoku Univ, Sendai, Miyagi, Japan; [Fujihara, Kazuo] Fukushima Med Univ, Fukushima, Japan; [Fujihara, Kazuo] Southern TOHOKU Res Inst Neurosci STRINS, Koriyama, Fukushima, Japan; [Levy, Michael] Johns Hopkins Univ, Baltimore, MD USA; [Levy, Michael] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Levy, Michael] Harvard Med Sch, Boston, MA 02115 USA; [Palace, Jacqueline] John Radcliffe Hosp, Oxford, England; [Nakashima, Ichiro] Tohoku Med & Pharmaceut Univ, Sendai, Miyagi, Japan; [Terzi, Murat] Ondokuz Mayis Univ, Samsun, Turkey; [Totolyan, Natalia] First Pavlov State Med Univ St Petersburg, St Petersburg, Russia; [Viswanathan, Shanthi] Kuala Lumpur Hosp, Kuala Lumpur, Malaysia; [Wang, Kai-Chen] Cheng Hsin Gen Hosp, Taipei, Taiwan; [Wang, Kai-Chen] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Pace, Amy; Fujita, Kenji P.; Yountz, Marcus; Armstrong, Roisin] Alexion Pharmaceut, Boston, MA USA; [Wingerchuk, Dean M.] Mayo Clin, Scottsdale, AZ USA | en_US |
| dc.description.woscitationindex | Science Citation Index Expanded - Conference Proceedings Citation Index - Science | |
| dc.identifier.issn | 0028-3878 | |
| dc.identifier.issn | 1526-632X | |
| dc.identifier.issue | 15 | en_US |
| dc.identifier.scopusquality | Q1 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12712/39510 | |
| dc.identifier.volume | 94 | en_US |
| dc.identifier.wos | WOS:000536058003181 | |
| dc.identifier.wosquality | Q1 | |
| dc.language.iso | en | en_US |
| dc.publisher | Lippincott Williams & Wilkins | en_US |
| dc.relation.ispartof | Neurology | en_US |
| dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.title | Impact of Eculizumab on Hospitalization Rates and Relapse Treatment in Patients with Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder: the Phase 3 PREVENT Study | en_US |
| dc.type | Conference Object | en_US |
| dspace.entity.type | Publication |
